Selected research
Industry Research
Vasodilators Industry Research Report 2026
Market perspective
The global Vasodilators market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Vasodilators is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Vasodilators is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Vasodilators include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Vasodilators market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vasodilators Market by Company
Teva Pharmaceutical
Sanofi
Jhonson and Johnson
Novartis
Merck
Eli Lilly
Pfizer
GSK
Bayer
Bristol-Myers Squibb
Astra Zeneca
Vasodilators Segment by Type
Venous Dilators
Mixed Dilators
Arterial Dilators
Vasodilators Segment by Application
Heart Failure
Angina
Hypertension
Vasodilators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasodilators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vasodilators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasodilators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vasodilators manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vasodilators by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vasodilators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Venous Dilators
- Mixed Dilators
- Arterial Dilators
Applications
- Heart Failure
- Angina
- Hypertension
Companies covered
- Teva Pharmaceutical
- Sanofi
- Jhonson and Johnson
- Novartis
- Merck
- Eli Lilly
- Pfizer
- GSK
- Bayer
- Bristol-Myers Squibb
- Astra Zeneca
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vasodilators Market Size (2021-2032)
- 2.2.2 Global Vasodilators Sales (2021-2032)
- 2.2.3 Global Vasodilators Market Average Price (2021-2032)
- 2.3 Vasodilators by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Venous Dilators
- 2.3.3 Mixed Dilators
- 2.3.4 Arterial Dilators
- 2.4 Vasodilators by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Heart Failure
- 2.4.3 Angina
- 2.4.4 Hypertension
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vasodilators Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vasodilators Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Vasodilators Revenue of Manufacturers (2021-2026)
- 3.4 Global Vasodilators Average Price by Manufacturers (2021-2026)
- 3.5 Global Vasodilators Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vasodilators, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vasodilators, Product Type & Application
- 3.8 Global Manufacturers of Vasodilators, Established Date
- 3.9 Global Vasodilators Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Vasodilators Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Vasodilators Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Jhonson and Johnson
- 4.3.1 Jhonson and Johnson Company Information
- 4.3.2 Jhonson and Johnson Business Overview
- 4.3.3 Jhonson and Johnson Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jhonson and Johnson Vasodilators Product Portfolio
- 4.3.5 Jhonson and Johnson Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Vasodilators Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Vasodilators Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Company Information
- 4.6.2 Eli Lilly Business Overview
- 4.6.3 Eli Lilly Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eli Lilly Vasodilators Product Portfolio
- 4.6.5 Eli Lilly Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Vasodilators Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 GSK
- 4.8.1 GSK Company Information
- 4.8.2 GSK Business Overview
- 4.8.3 GSK Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GSK Vasodilators Product Portfolio
- 4.8.5 GSK Recent Developments
- 4.9 Bayer
- 4.9.1 Bayer Company Information
- 4.9.2 Bayer Business Overview
- 4.9.3 Bayer Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bayer Vasodilators Product Portfolio
- 4.9.5 Bayer Recent Developments
- 4.10 Bristol-Myers Squibb
- 4.10.1 Bristol-Myers Squibb Company Information
- 4.10.2 Bristol-Myers Squibb Business Overview
- 4.10.3 Bristol-Myers Squibb Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol-Myers Squibb Vasodilators Product Portfolio
- 4.10.5 Bristol-Myers Squibb Recent Developments
- 4.11 Astra Zeneca
- 4.11.1 Astra Zeneca Company Information
- 4.11.2 Astra Zeneca Business Overview
- 4.11.3 Astra Zeneca Vasodilators Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Astra Zeneca Vasodilators Product Portfolio
- 4.11.5 Astra Zeneca Recent Developments
5 Global Vasodilators Market Scenario by Region
- 5.1 Global Vasodilators Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vasodilators Sales by Region: 2021-2032
- 5.2.1 Global Vasodilators Sales by Region: 2021-2026
- 5.2.2 Global Vasodilators Sales by Region: 2027-2032
- 5.3 Global Vasodilators Revenue by Region: 2021-2032
- 5.3.1 Global Vasodilators Revenue by Region: 2021-2026
- 5.3.2 Global Vasodilators Revenue by Region: 2027-2032
- 5.4 North America Vasodilators Market Facts & Figures by Country
- 5.4.1 North America Vasodilators Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vasodilators Sales by Country (2021-2032)
- 5.4.3 North America Vasodilators Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Vasodilators Market Facts & Figures by Country
- 5.5.1 Europe Vasodilators Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vasodilators Sales by Country (2021-2032)
- 5.5.3 Europe Vasodilators Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Vasodilators Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vasodilators Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vasodilators Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vasodilators Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vasodilators Market Facts & Figures by Country
- 5.7.1 South America Vasodilators Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vasodilators Sales by Country (2021-2032)
- 5.7.3 South America Vasodilators Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Vasodilators Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vasodilators Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vasodilators Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vasodilators Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Vasodilators Sales by Type (2021-2032)
- 6.1.1 Global Vasodilators Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Vasodilators Sales Market Share by Type (2021-2032)
- 6.2 Global Vasodilators Revenue by Type (2021-2032)
- 6.2.1 Global Vasodilators Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vasodilators Revenue Market Share by Type (2021-2032)
- 6.3 Global Vasodilators Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vasodilators Sales by Application (2021-2032)
- 7.1.1 Global Vasodilators Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Vasodilators Sales Market Share by Application (2021-2032)
- 7.2 Global Vasodilators Revenue by Application (2021-2032)
- 7.2.1 Global Vasodilators Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vasodilators Revenue Market Share by Application (2021-2032)
- 7.3 Global Vasodilators Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vasodilators Value Chain Analysis
- 8.1.1 Vasodilators Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vasodilators Production Mode & Process
- 8.2 Vasodilators Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vasodilators Distributors
- 8.2.3 Vasodilators Customers
9 Global Vasodilators Analyzing Market Dynamics
- 9.1 Vasodilators Industry Trends
- 9.2 Vasodilators Industry Drivers
- 9.3 Vasodilators Industry Opportunities and Challenges
- 9.4 Vasodilators Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst